查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585723

全球採血採血針市場：按類型、紗布尺寸、年齡層、最終用戶、應用分類 - 2025-2030 年預測

Blood Lancet Market by Type (Home Care Lancet, Safety Lancets, Standard Lancets), Gauze Size (22G, 31 G, Above 38 G), Age Group, End-Users, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，全球採血採血針市場價值為18.4億美元，預計到2024年將達到20.4億美元，複合年成長率為11.09%，到2030年將達到38.5億美元。 據預測，這一數字將會實現。

採血採血針是一種小型醫療設備，主要用於刺穿皮膚收集血液樣本以用於診斷目的。其應用範圍包括糖尿病管理、膽固醇測試和其他健康監測需求。採血採血針的需求在於其促進快速、微創血液採樣的作用，這對於需要定期監測的患者（例如使用血糖儀的糖尿病患者）至關重要。採血採血針的主要最終使用者包括醫院、診所和診斷實驗室，以及家用管理慢性病的個人使用者。糖尿病盛行率的不斷上升、醫療診斷技術的進步以及人們對自我檢測套組的認知和需求的不斷提高推動了市場的成長。該市場的新機會包括對複雜、減輕痛苦的採血針設計的需求增加，以及與健康監測應用程式的數位整合，以增強患者體驗和資料收集準確性。

主要市場統計
基準年[2023] 18.4億美元
預測年份 [2024] 20.4億美元
預測年份 [2030] 38.5億美元
複合年成長率（%） 11.09%

然而，諸如感染風險、處置問題以及採血針與特定血液樣本分析儀的不同相容性等挑戰可能會阻礙市場成長。監管障礙和替代血液採樣方法的可用性也可能是限制因素。開發更舒適、更有效率的採血針以及整合物聯網技術以自動化資料收集和提高準確性等創新描述了巨大的成長空間。此外，對減少疼痛和改善使用者體驗的採血針材料的研究具有巨大的潛力。

此市場的特點是競爭格局既有大型醫療設備製造商，也有中小型利基市場參與者。公司可以透過關注永續性來利用市場機會，例如開發環保的一次性採血針，以及擴展到醫療基礎設施正在改善的新興市場。此外，透過與數位健康平台合作，我們可以利用資料分析來提高用戶參與度和合規性。

市場動態：揭示快速發展的全球採血採血針市場的關鍵市場洞察

全球採血採血針市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 個體糖尿病盛行率和加強護理的需要
    • 透過線上分銷管道實現採血針的高可用性
    • 政府在糖尿病篩檢宣傳活動中的舉措
  • 市場限制因素
    • 皮膚穿刺精度差和採血針安全問題
  • 市場機會
    • 技術先進的採血針設備的創新
    • 居家醫療和遠端醫療迅速普及
  • 市場問題
    • 政府對採血針的使用和銷售有嚴格的規定

波特的五力：駕馭全球採血採血針市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解對全球採血採血針市場的外部影響

外部宏觀環境因素在塑造全球採血採血針市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解全球採血採血針市場的競爭狀況

對全球採血採血針市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

全球 FPNV 定位矩陣採血採血針市場供應商績效評估

FPNV 定位矩陣是評估全球採血採血針市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製全球採血採血針市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對全球血採血針市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 個體糖尿病盛行率和加強護理的需要
      • 透過線上分銷管道實現採血針的高可用性
      • 政府在糖尿病篩檢宣傳活動中的舉措
    • 抑制因素
      • 與採血針相關的皮膚穿刺不準確性和安全性問題
    • 機會
      • 技術先進的採血針設備的創新
      • 居家醫療和遠端醫療的快速採用
    • 任務
      • 政府對採血針的使用和銷售有嚴格的規定
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章全球採血採血針市場：依類型

  • 介紹
  • 居家醫療採血針
  • 安全採血針
    • 手動的
    • 壓力驅動
  • 標準採血針

第7章 採血採血針的全球市場：依紗布尺寸分類

  • 介紹
  • 22G
  • 31G
  • 38G以上
  • 22G以下

第8章全球採血採血針市場：依年齡層

  • 介紹
  • 成人
  • 兒科的

第9章全球採血採血針市場：依最終用戶分類

  • 介紹
  • 血庫
  • 居家醫療
  • 醫院/診所

第10章 採血採血針的全球市場：依應用分類

  • 介紹
  • 膽固醇測試
  • 血糖測試
  • 血紅素測試

第11章 美洲採血採血針的世界市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太血採血針全球市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲採血採血針的全球市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • AdvaCare Pharma
  • AMBISEA Technology Corp., Ltd.
  • Amkay Products Pvt. Ltd.
  • B. Braun Melsungen AG
  • Becton, Dickinson & Company
  • BioCare Corporation
  • CML BIoTech Ltd.
  • F. Hoffmann-La Roche AG
  • FL MEDICAL srl
  • Haemonetics Corporation
  • Improve Medical
  • Natus Medical by ARCHIMED
  • Nipro Medical Corporation
  • Owen Mumford Ltd.
  • SARSTEDT AG & Co. KG
  • Shandong Lianfa Medical Plastic Products Co., Ltd.
  • SteriLance Medical（Suzhou）Inc.
  • Terumo Corporation
  • Ypsome AD
Product Code: MRR-742BD517BEC2

The Blood Lancet Market was valued at USD 1.84 billion in 2023, expected to reach USD 2.04 billion in 2024, and is projected to grow at a CAGR of 11.09%, to USD 3.85 billion by 2030.

Blood lancets are small medical devices used to puncture the skin to obtain a blood sample, primarily for diagnostic purposes. Their application spans diabetes management, cholesterol testing, and other health monitoring needs. The necessity of blood lancets lies in their role in facilitating quick and minimally invasive blood draws, essential for patients requiring regular monitoring, such as diabetics using glucose meters. The primary end-users of blood lancets include hospitals, clinics, diagnostic laboratories, as well as individual users managing chronic illnesses at home. Market growth is driven by an increasing prevalence of diabetes and technological advancements in healthcare diagnostics, as well as growing awareness and demand for self-testing kits. Emerging opportunities in the market include the increasing demand for sophisticated, less painful lancet designs and digital integration with health-monitoring apps to enhance patient experience and data collection accuracy.

KEY MARKET STATISTICS
Base Year [2023] USD 1.84 billion
Estimated Year [2024] USD 2.04 billion
Forecast Year [2030] USD 3.85 billion
CAGR (%) 11.09%

However, challenges such as the risk of infection, disposal issues, and the variability in lancet compatibility with certain blood sample analysis devices can hinder market growth. Regulatory hurdles and the availability of alternative blood sampling methods can also be limiting factors. Innovations such as the development of more comfortable and efficient lancets and the integration of IoT technology to automate data collection and enhance precision offer substantial room for growth. Furthermore, research into lancet materials that minimize pain and improve user experience presents significant potential.

The market is characterized by a competitive landscape with both large healthcare device manufacturers and smaller niche companies. Companies can capitalize on market opportunities by focusing on sustainability, such as developing eco-friendly disposable lancets, and expanding into emerging markets where healthcare infrastructure is being improved. Emphasizing on user education to promote regular testing can further cement market position while advancing partnerships with digital health platforms can leverage data analytics to enhance user engagement and compliance.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Lancet Market

The Blood Lancet Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of diabetes among individuals and need for enhanced care
    • High availability of lancet through online distribution channels
    • Government initiatives in diabetes check up campaigns
  • Market Restraints
    • Inaccuracy in skin puncture and safety issues associated with lancet
  • Market Opportunities
    • Innovations of technologically advanced lancet devices
    • Rapid adoption of home based healthcare and telemedicine
  • Market Challenges
    • Stringent government regulations associated with lancet use and marketing

Porter's Five Forces: A Strategic Tool for Navigating the Blood Lancet Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Lancet Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Lancet Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Lancet Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Lancet Market

A detailed market share analysis in the Blood Lancet Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Lancet Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Lancet Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Lancet Market

A strategic analysis of the Blood Lancet Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Lancet Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., AdvaCare Pharma, AMBISEA Technology Corp., Ltd., Amkay Products Pvt. Ltd., B. Braun Melsungen AG, Becton, Dickinson & Company, BioCare Corporation, CML Biotech Ltd., F. Hoffmann-La Roche AG, FL MEDICAL s.r.l., Haemonetics Corporation, Improve Medical, Natus Medical by ARCHIMED, Nipro Medical Corporation, Owen Mumford Ltd., SARSTEDT AG & Co. KG, Shandong Lianfa Medical Plastic Products Co., Ltd., SteriLance Medical (Suzhou) Inc., Terumo Corporation, and Ypsome AD.

Market Segmentation & Coverage

This research report categorizes the Blood Lancet Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Home Care Lancet, Safety Lancets, and Standard Lancets. The Safety Lancets is further studied across Manually and Pressure Activated.
  • Based on Gauze Size, market is studied across 22G, 31 G, Above 38 G, and Below.
  • Based on Age Group, market is studied across Adult and Pediatrics.
  • Based on End-Users, market is studied across Blood Banks, Home Care, and Hospitals & Clinics.
  • Based on Application, market is studied across Cholesterol Testing, Glucose Testing, and Hemoglobin Testing.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of diabetes among individuals and need for enhanced care
      • 5.1.1.2. High availability of lancet through online distribution channels
      • 5.1.1.3. Government initiatives in diabetes check up campaigns
    • 5.1.2. Restraints
      • 5.1.2.1. Inaccuracy in skin puncture and safety issues associated with lancet
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations of technologically advanced lancet devices
      • 5.1.3.2. Rapid adoption of home based healthcare and telemedicine
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations associated with lancet use and marketing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Lancet Market, by Type

  • 6.1. Introduction
  • 6.2. Home Care Lancet
  • 6.3. Safety Lancets
    • 6.3.1. Manually
    • 6.3.2. Pressure Activated
  • 6.4. Standard Lancets

7. Blood Lancet Market, by Gauze Size

  • 7.1. Introduction
  • 7.2. 22G
  • 7.3. 31 G
  • 7.4. Above 38 G
  • 7.5. Below

8. Blood Lancet Market, by Age Group

  • 8.1. Introduction
  • 8.2. Adult
  • 8.3. Pediatrics

9. Blood Lancet Market, by End-Users

  • 9.1. Introduction
  • 9.2. Blood Banks
  • 9.3. Home Care
  • 9.4. Hospitals & Clinics

10. Blood Lancet Market, by Application

  • 10.1. Introduction
  • 10.2. Cholesterol Testing
  • 10.3. Glucose Testing
  • 10.4. Hemoglobin Testing

11. Americas Blood Lancet Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Blood Lancet Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Blood Lancet Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACON Laboratories, Inc.
  • 3. AdvaCare Pharma
  • 4. AMBISEA Technology Corp., Ltd.
  • 5. Amkay Products Pvt. Ltd.
  • 6. B. Braun Melsungen AG
  • 7. Becton, Dickinson & Company
  • 8. BioCare Corporation
  • 9. CML Biotech Ltd.
  • 10. F. Hoffmann-La Roche AG
  • 11. FL MEDICAL s.r.l.
  • 12. Haemonetics Corporation
  • 13. Improve Medical
  • 14. Natus Medical by ARCHIMED
  • 15. Nipro Medical Corporation
  • 16. Owen Mumford Ltd.
  • 17. SARSTEDT AG & Co. KG
  • 18. Shandong Lianfa Medical Plastic Products Co., Ltd.
  • 19. SteriLance Medical (Suzhou) Inc.
  • 20. Terumo Corporation
  • 21. Ypsome AD

LIST OF FIGURES

  • FIGURE 1. BLOOD LANCET MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD LANCET MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD LANCET MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD LANCET MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD LANCET MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD LANCET MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD LANCET MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BLOOD LANCET MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BLOOD LANCET MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BLOOD LANCET MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES BLOOD LANCET MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES BLOOD LANCET MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. BLOOD LANCET MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. BLOOD LANCET MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD LANCET MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD LANCET MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD LANCET MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD LANCET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD LANCET MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD LANCET MARKET SIZE, BY HOME CARE LANCET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD LANCET MARKET SIZE, BY MANUALLY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD LANCET MARKET SIZE, BY PRESSURE ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD LANCET MARKET SIZE, BY STANDARD LANCETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD LANCET MARKET SIZE, BY 22G, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD LANCET MARKET SIZE, BY 31 G, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD LANCET MARKET SIZE, BY ABOVE 38 G, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD LANCET MARKET SIZE, BY BELOW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD LANCET MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD LANCET MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD LANCET MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD LANCET MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD LANCET MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD LANCET MARKET SIZE, BY CHOLESTEROL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD LANCET MARKET SIZE, BY GLUCOSE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD LANCET MARKET SIZE, BY HEMOGLOBIN TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS BLOOD LANCET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES BLOOD LANCET MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. BLOOD LANCET MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 281. BLOOD LANCET MARKET, FPNV POSITIONING MATRIX, 2023